“Patents 4 Patients” Program Extended to 2022
Last week, the USPTO announced that the popular Patents for Patients pilot program will be extended an additional two years. …
Read more
MMWV Law Immunotherapy Client Receives 100th Patent
United States Patent and Trademark Office awards Immatics patent for innovative immunotherapies FREDERICK, Md. (January 3, 2019) – McBee, Moore,…
USPTO’s Patents for Patients Program – A Good Way to Expedite Patent Grant of Cancer-Related Applications
The USPTO’s Patents for Patients program or Cancer Immunotherapy Pilot Program (“the program”) represents a good option for those looking…
USPTO Extends "Patents 4 Patients" Pilot Program
Last summer, we wrote about the “Patents 4 Patients” Cancer Immunotherapy Pilot Program launched by the USPTO. At the program’s…